JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M413594200 on April 25, 2005

J. Biol. Chem., Vol. 280, Issue 27, 25788-25801, July 8, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/27/25788    most recent
M413594200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mercer, S. E.
Right arrow Articles by Friedman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mercer, S. E.
Right arrow Articles by Friedman, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mirk/Dyrk1B Mediates Survival during the Differentiation of C2C12 Myoblasts*

Stephen E. Mercer, Daina Z. Ewton, Xiaobing Deng, Seunghwan Lim, Thomas R. Mazur, and Eileen Friedman{ddagger}

From the Department of Pathology, Upstate Medical University, State University of New York, Syracuse, New York 13210

The kinase Mirk/dyrk1B is essential for the differentiation of C2C12 myoblasts. Mirk reinforces the G0/G1 arrest state in which differentiation occurs by directly phosphorylating and stabilizing p27Kip1 and destabilizing cyclin D1. We now demonstrate that Mirk is anti-apoptotic in myoblasts. Knockdown of endogenous Mirk by RNA interference activated caspase 3 and decreased myoblast survival by 75%, whereas transient overexpression of Mirk increased cell survival. Mirk exerts its anti-apoptotic effects during muscle differentiation at least in part through effects on the cell cycle inhibitor and pro-survival molecule p21Cip1. Overexpression and RNA interference experiments demonstrated that Mirk phosphorylates p21 within its nuclear localization domain at Ser-153 causing a portion of the typically nuclear p21 to localize in the cytoplasm. Phosphomimetic GFP-p21-S153D was pancellular in both cycling C2C12 myoblasts and NIH3T3 cells. Endogenous Mirk in myotubes and overexpressed Mirk in NIH3T3 cells were able to cause the pancellular localization of wild-type GFP-p21 but not the nonphosphorylatable mutant GFP-p21-S153A. Translocation to the cytoplasm enables p21 to block apoptosis through inhibitory interaction with pro-apoptotic molecules. Phosphomimetic p21-S153D was more effective than wild-type p21 in blocking the activation of caspase 3. Transient expression of p21-S153D also increased myoblast viability in colony forming assays, whereas the p21-S153A mutant had no effect. This Mirk-dependent change in p21 intracellular localization is a natural part of myoblast differentiation. Endogenous p21 localized exclusively to the nuclei of proliferating myoblasts but was also found in the cytoplasm of post-mitotic multinucleated myotubes and adult human skeletal myofibers.


Received for publication, December 2, 2004 , and in revised form, March 29, 2005.

* This work was supported by United States Public Health Service Award RO1 CA67405 (to E. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Pathology Dept., Upstate Medical University, 750 East Adams St., Syracuse, NY 13210. Tel.: 315-464-7138; Fax: 315-464-8419; E-mail: friedmae{at}upstate.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Zhang, J. E. Lee, J. Wilusz, and C. J. Wilusz
The RNA-binding Protein CUGBP1 Regulates Stability of Tumor Necrosis Factor mRNA in Muscle Cells: IMPLICATIONS FOR MYOTONIC DYSTROPHY
J. Biol. Chem., August 15, 2008; 283(33): 22457 - 22463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Oikawa, E. Matsuda, T. Nishii, Y. Ishida, and M. Kawaichi
Down-regulation of CIBZ, a Novel Substrate of Caspase-3, Induces Apoptosis
J. Biol. Chem., May 23, 2008; 283(21): 14242 - 14247.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Kawano, Y. Matsuoka, Y. Oke, Y. Higo, M. Terada, X. D. Wang, N. Nakai, H. Fukuda, S. Imajoh-Ohmi, and Y. Ohira
Role(s) of nucleoli and phosphorylation of ribosomal protein S6 and/or HSP27 in the regulation of muscle mass
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C35 - C44.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. E. Mercer, D. Z. Ewton, S. Shah, A. Naqvi, and E. Friedman
Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas.
Cancer Res., May 15, 2006; 66(10): 5143 - 5150.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Deng, D. Z. Ewton, S. Li, A. Naqvi, S. E. Mercer, S. Landas, and E. Friedman
The Kinase Mirk/Dyrk1B Mediates Cell Survival in Pancreatic Ductal Adenocarcinoma.
Cancer Res., April 15, 2006; 66(8): 4149 - 4158.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Jin, S. Lim, S. E. Mercer, and E. Friedman
The Survival Kinase Mirk/dyrk1B Is Activated through Rac1-MKK3 Signaling
J. Biol. Chem., December 23, 2005; 280(51): 42097 - 42105.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.